 Home > Medical News > Medicines Company News > BIOSET has entered into a collaboration with Bonn Biotech on the development of cell therapy drugs based on TCR-like antibodies

BIOSET has entered into a collaboration with Bonn Biotech on the development of cell therapy drugs based on TCR-like antibodies

 Last Update: 2022-09-21
 Source: Internet
 Author: User

Tags

sertraline drug test

human genome sciences

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 8, 2022, BIOSAITU (Beijing) Pharmaceutical Technology Co.

Based on the fully independent intellectual property rights of the renmiceTM platform (RenMab? and RenLite? mice), BIOSAI further developed human HLA transgenic mice HLA/RenMab, and combined with the advantages of high-throughput antibody screening, established a TCR-like antibody technology platform, focusing on the discovery of antibodies against intracellular tumor-related antigens, breaking through the limitation that conventional antibodies can only recognize extracellular antigens

Relying on a number of world-class technology platforms independently developed and established, including the genome-wide T cell signal optimization technology platform (GSOP for T-cell), TCR high-throughput screening platform (HAP for TCR), personalized TCR-T cell production technology platform, T cell efficient delivery system platform (TDP), etc.

The two sides complement each other's strengths, and this strong alliance will promote the development of new cell therapy drugs and expand the potential of immunotherapy for the benefit of patients

On September 8, 2022, BIOSAITU (Beijing) Pharmaceutical Technology Co.

The two sides complement each other's strengths, and this strong alliance will promote the development of new cell therapy drugs and expand the potential of immunotherapy for the benefit of patients

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.